Literature DB >> 11718161

A look back at 2000: overabundance and deregulation.

.   

Abstract

(1) Ten or 20 years ago about half the new drugs released each year provided no significant advantage for the patient, relative to existing therapeutic means. This proportion has been increasing gradually over the last 5 years. (2) In 2000, approximately 80% of "new" drugs in fact provided "Nothing New" for the patient according to our rating system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718161

Source DB:  PubMed          Journal:  Prescrire Int        ISSN: 1167-7422


  4 in total

1.  Direct-to-consumer prescription drug advertising in Canada: permission by default?

Authors:  David M Gardner; Barbara Mintzes; Aleck Ostry
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

2.  Enhancing prescription drug innovation and adoption.

Authors:  G Caleb Alexander; Alec B O'Connor; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

3.  Toward a definition of pharmaceutical innovation.

Authors:  Steven Morgan; Ruth Lopert; Devon Greyson
Journal:  Open Med       Date:  2008-01-30

4.  The courage to change the rules: a proposal for an essential health R&D treaty.

Authors:  Nicoletta Dentico; Nathan Ford
Journal:  PLoS Med       Date:  2005-02-22       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.